 |
ATOLL Seen as Supporting Enoxaparin Over Standard Heparin in Primary PCI
(30 Aug 2010)
| |
|
|
No man is an island, nor is any one study. In the case of ATOLL, the nonsignificant primary-end-point difference between ...
| |
 |
One Third of First-Time Pregnancies Delivered by Cesarean
(30 Aug 2010)
| |
|
|
The rate of cesarean deliveries in the United States continues to rise. Medscape Medical News
| |
 |
CTT Meta-Analysis: No Cancer Risk With Statins, Low LDL-Cholesterol Levels
(30 Aug 2010)
| |
|
|
Investigators report that statin therapy had no adverse effect on any cancer type, irrespective of how long patients took ...
| |
 |
Colchicine Halves Incidence of Postpericardiotomy Syndrome
(30 Aug 2010)
| |
|
|
The first large-scale double-blind, placebo-controlled trial to test the efficacy of colchicine to prevent the development ...
| |
 |
Four-Year REACH Analysis Grasps a Variety of Clinical Factors That Flag Atherothrombosis Risk
(30 Aug 2010)
| |
|
|
The 45,277-patient REACH registry reveals a variety of risk factors that will help...
| |
 |
Johnson & Johnson Unit Recalls 2 Hip Replacement Systems
(30 Aug 2010)
| |
|
|
Earlier this month, the FDA sent a warning letter...
| |
 |
Mutations in Single Gene Cause Variety of Malformations in Cerebral Cortex
(30 Aug 2010)
| |
|
|
Whole-exome sequencing is effective for...
| |
 |
ISAR-REACT 3A: Lower Heparin Dose Preferable in Elective PCI
(30 Aug 2010)
| |
|
|
The 100-U/kg heparin dose was suggested to be better than the 140-U/kg dose and "noninferior" to bivalirudin in this trial ...
| |
 |
New Class of Antiplatelet Agents in Clinical Trials
(30 Aug 2010)
| |
|
|
A new, investigational antiplatelet agent, atopaxar--which acts via a different pathway from that of aspirin and drugs such ...
| |
 |
INNOVATE PCI: Elinogrel, a New Antiplatelet Agent, Passes Initial Hurdles
(30 Aug 2010)
| |
|
|
Investigators showed that treatment with oral and intravenous elinogrel had more rapid antiplatelet effects than clopidogrel ...
| |
 |
Meta-Analysis Shows Newer P2Y12 Inhibitors Decrease Mortality After PCI Compared With Clopidogrel
(30 Aug 2010)
| |
|
|
The benefits of the newer P2Y12 inhibitors...
| |
 |
Exercise Can Treat Cardiovascular Disease as Well as Prevent It
(30 Aug 2010)
| |
|
|
Experts presented research on exercise in patients who have already been diagnosed with cardiovascular disease, showing ...
| |
 |
LESSON I: Everolimus Bests Sirolimus in Nonrandomized DES Face-Off
(30 Aug 2010)
| |
|
|
While the propensity-matched analysis narrowly missed its primary end point, secondary end points pointed to significant ...
| |
 |
Guidelines Updated for Influenza Vaccination and Antiviral Therapy in Children
(30 Aug 2010)
| |
|
|
The American Academy of Pediatrics has updated guidelines for use of trivalent seasonal influenza vaccine and antiviral ...
| |
 |
Prostate Cancer in the Family: Risks Are Inflated
(30 Aug 2010)
| |
|
|
Family history is an important risk factor for prostate cancer,...
| |
 |
FDA Panel Says No to Sodium Oxybate for Fibromyalgia
(22 Aug 2010)
| |
|
|
A joint FDA advisory committee has voted against approval of sodium oxybate for fibromyalgia. Medscape Medical ...
| |
 |
FDA Clears Percutaneous Microwave Tissue Ablation Device
(20 Aug 2010)
| |
|
|
The FDA has granted 501(k) clearance for a percutaneous microwave tissue ablation system to destroy unwanted soft tissue ...
| |
 |
WHO urges countries to take measures to combat antimicrobial resistance
(20 Aug 2010)
| |
|
|
20 August 2010 -- WHO suggests that countries should be prepared to implement hospital infection control measures to limit the spread of multi-drug resistant strains and to reinforce national policy on ...
| |
 |
CDC: Adolescent Vaccinations Increased Substantially From 2008 to 2009, Reaching Several Healthy People 2010 Immunization Goals
(20 Aug 2010)
| |
|
|
Vaccination coverage among adolescents aged 13 to 17 years increased from 2008 to 2009, although considerable variability ...
| |
 |
Fear of Falling Linked to Future Falls in Elderly
(20 Aug 2010)
| |
|
|
Seniors with an irrational fear...
| |